Covance Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Covance Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013487
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. It also offers services including laboratory testing for agrochemical, chemical and food industries. The early-stage development services that the company offers include preclinical and clinical pharmacology services and discovery support services. Its late-stage development services include Phase II-IV clinical development, central laboratory and market access services. The company operates across the US, Europe, South America and Asia-Pacific. Covance is headquartered in Princeton, New Jersey, the US.

Covance Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Covance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Covance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Covance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Covance Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Covance Inc, Medical Devices Deals, 2011 to YTD 2017 11
Covance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Covance Inc, Pharmaceuticals & Healthcare, Deal Details 14
Private Equity 14
Chicago Growth Partners Acquires Caprion Proteomics For US$29 Million 14
Partnerships 15
Emulate Enters into Agreement with Covance 15
Motif Bio Enters into Agreement with Covance 16
Covance Enters into Co-Development Agreement with Sihuan Pharma 17
Covance Enters into Co-Development Agreement with Novartis Institutes for BioMedical Research 18
Covance Enters into Research Agreement with Frenova Renal Research 19
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 20
Covance And Royal Liverpool and Broadgreen University Hospitals Enter Into Agreement To Offer Clinical Trials 21
GNS Healthcare Enters Into Co-Development Agreement With Covance 22
Bayer HealthCare Enters Into Agreement With Covance 23
Covance Enters Into Co-Development Agreement With Inserm Transfert And Inserm Transfert Initiative 24
Covance Enters Into Research Agreement With Institute for Systems Biology For Tumor Biology 25
Ingenuity Systems Enters Into Research Collaboration With Covance Genomics 26
Takeda Enters Into Co-Development Agreement With Covance 27
Debt Offering 28
Covance Completes Private Placement Of Notes Due 2023 For US$90 Million 28
Covance Completes Private Placement Of Notes Due 2018 For US$15 Million 29
Covance Completes Private Placement Of Notes Due 2020 For US$50 Million 30
Covance Completes Private Placement Of Notes Due 2025 For US$95 Million 31
Asset Transactions 32
LabCorp Acquires High-Complexity Genomic Lab From Covance 32
Acquisition 33
LabCorp Acquires Chiltern International for USD1.2 Billion 33
Chiltern International Acquires Integrated Development Associates 35
LabCorp Acquires Covance for USD6.1 Billion 36
Chiltern International Acquires Pacific Clinical Research 38
BioLegend Acquires Covance Antibody Services from Covance 39
Chiltern Acquires Ockham, Contract Research Organization 40
Covance Acquires Medaxial 41
Kester Capital Sells Its Stake In Chiltern For US$220 Million 42
Smithers Viscient Services Completes Acquisition Of Environmental Sciences From Covance 43
Covance Acquires Trac Microbiology, Microbiology And Chemistry Laboratory 44
Chiltern International Acquires Additional Stake In Endpoint 45
Covance Inc – Key Competitors 46
Covance Inc – Key Employees 47
Covance Inc – Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 53
Product News 53
Sep 05, 2016: PCI Biotech Announces First subject dosed in the fimaVACC phase I study 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Covance Inc, Pharmaceuticals & Healthcare, Key Facts 2
Covance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Covance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Covance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Covance Inc, Deals By Therapy Area, 2011 to YTD 2017 10
Covance Inc, Medical Devices Deals, 2011 to YTD 2017 11
Covance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Chicago Growth Partners Acquires Caprion Proteomics For US$29 Million 14
Emulate Enters into Agreement with Covance 15
Motif Bio Enters into Agreement with Covance 16
Covance Enters into Co-Development Agreement with Sihuan Pharma 17
Covance Enters into Co-Development Agreement with Novartis Institutes for BioMedical Research 18
Covance Enters into Research Agreement with Frenova Renal Research 19
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 20
Covance And Royal Liverpool and Broadgreen University Hospitals Enter Into Agreement To Offer Clinical Trials 21
GNS Healthcare Enters Into Co-Development Agreement With Covance 22
Bayer HealthCare Enters Into Agreement With Covance 23
Covance Enters Into Co-Development Agreement With Inserm Transfert And Inserm Transfert Initiative 24
Covance Enters Into Research Agreement With Institute for Systems Biology For Tumor Biology 25
Ingenuity Systems Enters Into Research Collaboration With Covance Genomics 26
Takeda Enters Into Co-Development Agreement With Covance 27
Covance Completes Private Placement Of Notes Due 2023 For US$90 Million 28
Covance Completes Private Placement Of Notes Due 2018 For US$15 Million 29
Covance Completes Private Placement Of Notes Due 2020 For US$50 Million 30
Covance Completes Private Placement Of Notes Due 2025 For US$95 Million 31
LabCorp Acquires High-Complexity Genomic Lab From Covance 32
LabCorp Acquires Chiltern International for USD1.2 Billion 33
Chiltern International Acquires Integrated Development Associates 35
LabCorp Acquires Covance for USD6.1 Billion 36
Chiltern International Acquires Pacific Clinical Research 38
BioLegend Acquires Covance Antibody Services from Covance 39
Chiltern Acquires Ockham, Contract Research Organization 40
Covance Acquires Medaxial 41
Kester Capital Sells Its Stake In Chiltern For US$220 Million 42
Smithers Viscient Services Completes Acquisition Of Environmental Sciences From Covance 43
Covance Acquires Trac Microbiology, Microbiology And Chemistry Laboratory 44
Chiltern International Acquires Additional Stake In Endpoint 45
Covance Inc, Key Competitors 46
Covance Inc, Key Employees 47
Covance Inc, Other Locations 48
Covance Inc, Subsidiaries 51

★海外企業調査レポート[Covance Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TransMedics Inc:医療機器:M&Aディール及び事業提携情報
    Summary TransMedics Inc (TransMedics) is a medical device company that develops organ transplant systems. The company offers organ care systems that are used by surgeons in heart transplants and ex-vivo warm perfusion and assessment of donor organs for transplantation. Its organ care systems are als …
  • Wentworth Resources Ltd (WRL):企業の財務・戦略的SWOT分析
    Wentworth Resources Ltd (WRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • TSO3 Inc (TOS)-医療機器分野:企業M&A・提携分析
    Summary TSO3 Inc (TSO3) is a medical device company that designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization pr …
  • Trubnaya Metallurgicheskaya Kompaniya:企業の戦略・SWOT・財務情報
    Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report Summary Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Carlsberg AS (CARL B):企業の財務・戦略的SWOT分析
    Carlsberg AS (CARL B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Merit Medical Systems Inc (MMSI)-医療機器分野:企業M&A・提携分析
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • WS Atkins Plc:戦略・SWOT・企業財務分析
    WS Atkins Plc - Strategy, SWOT and Corporate Finance Report Summary WS Atkins Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Atara Biotherapeutics Inc (ATRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections. The company is evaluating its lead candidate tabelecleucel, formerly ATA129, in Phase 3 for the tr …
  • Jadranski naftovod dd (JNAF-R-A):企業の財務・戦略的SWOT分析
    Summary Jadranski naftovod dd (JANAF Plc) is an oil pipeline system managing company that operates crude oil transportation system and reloading and storage of crude oil and oil products. The company manages janaf system, an international crude oil transportation system. Its janaf systems consists o …
  • United Parcel Service Inc (UPS):企業の財務・戦略的SWOT分析
    United Parcel Service Inc (UPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Adamis Pharmaceuticals Corp (ADMP)-医療機器分野:企業M&A・提携分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe …
  • WABCO Holdings Inc.:企業の戦略・SWOT・財務情報
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tata Consultancy Services Limited:戦略・SWOT・企業財務分析
    Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Great Wolf Resorts Inc:戦略・SWOT・企業財務分析
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Citigroup Inc:戦略・SWOT・企業財務分析
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • PharmaLundensis AB:医療機器:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • Hindustan Unilever Ltd (HINDUNILVR):企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Novartis India Ltd (500672):企業の財務・戦略的SWOT分析
    Summary Novartis India Ltd (Novartis) a subsidiary of Novartis AG, is a healthcare company that offers pharmaceuticals, generic medicine and eye care products. The company’s pharmaceutical division develops drugs in the therapeutic areas of bone and pain, calcium portfolio, gynecology, oncology and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆